» Articles » PMID: 31722134

Risk of Malignancy in the Various Categories of the UK Royal College of Pathologists Thy Terminology for Thyroid FNA Cytology: A Systematic Review and Meta-analysis

Overview
Specialty Oncology
Date 2019 Nov 14
PMID 31722134
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The UK Royal College of Pathologists Thy terminology for reporting thyroid fine-needle aspiration cytology (FNAC), first published in 2009 is used throughout the United Kingdom and Ireland, in some parts of Italy and Switzerland and elsewhere. There is no review of the literature or meta-analysis of the risk of malignancy (ROM) in the various categories of the UK Thy terminology. The goal of this study was to establish the published ROM for each Thy category and compare the results with other existing terminology systems for which similar meta-analyses are available.

Methods: A comprehensive literature search of online databases was conducted in May 2019 to examine the ROMs for histologically proven nodules with preoperative FNAC classified according to the UK Thy terminology.

Results: Twenty-five articles were identified that showed results of both cytology and histology. Twelve of these articles were excluded to prevent a selection bias because they showed data in just 1 Thy category. In the remaining 13 articles, the pooled ROMs were as follows: Thy1, 12% (95% confidence interval [CI], 5%-22%); Thy2, 5% (95% CI, 3%-9%); Thy3, 22% (95% CI, 18%-26%); Thy3a, 25% (95% CI, 20%-31%); Thy3f, 31% (95% CI, 24%-39%); Thy4, 79% (95% CI, 70%-87%); and Thy5, 98% (95% CI, 97%-99%).

Conclusions: This meta-analysis shows results comparable to those of meta-analyses of other internationally recognized reporting terminologies for the pooled ROMs for surgically excised nodules in the various Thy reporting categories. There is comparatively little difference (only 6%) between the pooled ROMs of Thy3a and Thy3f surgically excised nodules.

Citing Articles

Investigation of artificial intelligence-based clinical decision support system's performance in reducing the fine needle aspiration rate of thyroid nodules: A pilot study.

Barnes A, White R, Venables H, Lam V, Vaidhyanath R Ultrasound. 2024; :1742271X241299220.

PMID: 39654847 PMC: 11625399. DOI: 10.1177/1742271X241299220.


Prevalence of Thyroid Nodules and Predictive Factors for their Malignancy: Is there any Correlation between Level of TSH and Type of Malignancy?: A Cross Sectional Study.

Moradi L, Hani Tabaei Zavareh M, Zaman F, Shareghi Bruojeni A, Taravati S, Naderi Boldaji H Adv Biomed Res. 2024; 13:48.

PMID: 39411703 PMC: 11478690. DOI: 10.4103/abr.abr_158_23.


Thyroid nodules: diagnosis and management.

Grani G, Sponziello M, Filetti S, Durante C Nat Rev Endocrinol. 2024; 20(12):715-728.

PMID: 39152228 DOI: 10.1038/s41574-024-01025-4.


Unveiling Variations: A Comprehensive Comparison of Five Globally Used Thyroid Cytology Reporting Systems With Histopathological Correlation.

Ramamoorthy S, Boddapati A, Venkata Renuka I, Imandi S, Mounica B Cureus. 2024; 16(2):e53359.

PMID: 38314381 PMC: 10831778. DOI: 10.7759/cureus.53359.


Indeterminate thyroid nodules (Thy3): malignancy rate and characteristics in a study of 118 patients.

Dimitriadis P, Moinie A, Michaels J, Bance R, Vijendren A, Mochloulis G Ann R Coll Surg Engl. 2023; 105(6):568-571.

PMID: 36927065 PMC: 10313444. DOI: 10.1308/rcsann.2022.0163.